Dr. Ashraf M. Elsayegh, MD

Dr. Elsayegh practices at Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services.

Dr. Elsayegh's NPI, 1073684056, was assigned on November 13, 2006. Dr. Elsayegh graduated from Ross University School of Medicine in 1998. Dr. Elsayegh's California license number on file is A77236.

Dr. Elsayegh's primary practice is Providence Saint John's Health Center, at 2121 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5511.

Dr. Elsayegh's primary practice is Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services. Dr. Elsayegh is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Inpatient Specialist of California PC. Dmand AI also links Dr. Elsayegh to 3 more hospitals, 6 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elsayegh practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Elsayegh's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Elsayegh is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Elsayegh's licenses on file in 3 states: California, New Mexico and Washington.

CMS data shows 3,594 Medicare services from Dr. Elsayegh across 7 procedure codes in 2024, for 680 Medicare patients. Medicare paid $358,397 for them.

CMS counts 680 Medicare patients who saw Dr. Elsayegh in 2024. The largest group is 65 to 74, with 242 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elsayegh's median patient age at 68, with 50% women.

In 2024, Dr. Elsayegh wrote 1,153 Medicare Part D claims for 136 patients. 66% of them were for generic drugs. CMS names the drug for 772 of them, across 35 drugs with 11 or more claims each, at $420,182 in total drug cost. In 2023, CMS named 771 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Elsayegh for performance year 2024, reported individually. Dr. Elsayegh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Elsayegh in 2010. Dr. Elsayegh's most frequent co-authors are Jason Cormier, MD, Timothy R. Cushing, MD and Dawn S. Eliashiv, MD.

Dmand AI links Dr. Elsayegh to 1 clinical trial. Conditions studied include Amyotrophic Lateral Sclerosis and TDP-43 Proteinopathies.

CMS Open Payments shows 744 general payments to Dr. Elsayegh from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Gilead Sciences, Inc. paid the most, $74,866. It also lists 1 research payment totaling $3,000 in 2016.

Dr. Elsayegh graduated from Ross University School of Medicine in 1998.

Dr. Elsayegh is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.